OKYO NASDAQ
OKYO Pharma Limited
1W: +6.5%
1M: -9.3%
3M: -8.7%
YTD: -34.1%
1Y: -26.9%
3Y: -22.6%
$1.47
+0.13 (+9.70%)
Weekly Expected Move ±7.9%
$1
$1
$1
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$21M
+470.4% ▲
5Y CAGR: +24.2%
Total Liabilities
$9M
-6.3% ▼
5Y CAGR: +37.3%
Shareholders Equity
$12M
+322.3% ▲
5Y CAGR: +18.3%
Cash & Investments
$21M
+1219.4% ▲
5Y CAGR: +24.5%
Total Debt
$0
+0.0% ▲
Net Debt
-$15M
-835.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $3M | $4M | $827K | $2M | $15M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $6M |
| Cash & ST Investments | $3M | $4M | $827K | $2M | $21M |
| Net Receivables | $883K | $980K | $581K | $2M | $171K |
| Inventory | -$1K | $170K | $0 | $0 | $0 |
| Other Current Assets | $1K | -$170K | $0 | $0 | $0 |
| Total Current Assets | $4M | $5M | $2M | $4M | $21M |
| Property, Plant & Equip. | $5K | $7K | $3K | $2K | $6K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $5K | $7K | $3K | $2K | $6K |
| Total Assets | $4M | $5M | $2M | $4M | $21M |
| — Liabilities — | |||||
| Accounts Payable | $518K | $1M | $6M | $8M | $7M |
| Short-Term Debt | $0 | $2M | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $323K | $1M | $0 | $0 | $0 |
| Total Current Liabilities | $1M | $7M | $7M | $9M | $9M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1M | $7M | $7M | $9M | $9M |
| — Equity — | |||||
| Common Stock | $124M | $0 | $143M | $0 | $174M |
| Retained Earnings | -$112M | -$126M | -$143M | -$143M | -$152M |
| Accumulated OCI | -$11M | -$8M | -$11M | -$11M | -$12M |
| Total Stockholders Equity | $3M | -$2M | -$6M | -$6M | $12M |
| Total Liabilities & Equity | $4M | $5M | $2M | $4M | $21M |
| — Key Metrics — | |||||
| Total Debt | $0 | $2M | $0 | $0 | $0 |
| Net Debt | -$3M | -$2M | -$827K | -$2M | -$15M |
| Total Investments | $0 | $0 | $0 | $0 | $6M |